量化门诊亲肠道抗菌药物治疗计划的成本节约:系统性审查和元分析
Solomon Ahmed Mohammed1,2, Jason A Roberts1,3,4,5, Manuel Mirón-Rubio6
1UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
JAC-antimicrobial resistance
|April 9, 2025
概括
门诊亲肠道抗菌疗法 (OPAT) 与住院治疗相比,显著降低了医疗保健成本. 这一系统性审查证实了OPAT的OPAT.
科学领域:
- 卫生经济学 卫生经济学
- 传染性疾病 传染性疾病
- 药物经济学 药物经济学
背景情况:
- 门诊亲肠道抗菌疗法 (OPAT) 旨在降低成本并改善患者的生活质量.
- 升级的通货膨胀引发了关于OPAT计划目前的成本效益的问题.
- 对医疗保健政策来说,量化OPAT与住院护理之间的成本节约至关重要.
研究的目的:
- 与传统的住院治疗相比,系统地审查和元分析OPAT的成本节约.
- 根据当前的经济状况,提供最新的成本最小化分析.
主要方法:
- 在多个数据库 (Cochrane Library,MEDLINE,Embase,PubMed,Web of Science) 中进行了系统的搜索.
- 包括研究中的成本数据被调整并膨胀至2023美元.
- 在元分析中使用随机效应模型来计算成本的平均差异.
主要成果:
- 系统性审查包括了20项涉及2790名患者的研究.
- 六项研究的元分析 (560名OPAT患者,491名住院患者) 显示了显著的成本降低.
- 在门诊环境中,亲肠道抗菌药物治疗的每次费用为5436.73美元,较低 (MD -5436.73美元;95%CI: -9589.24美元至 -1284.22美元).
结论:
- 与住院治疗相比,OPAT显示了显著的成本节约.
- 建议在未来的评估中对所有成本前景进行全面分析.
- 进一步的研究应该考虑各种各样的成本类型,以充分捕捉经济影响.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...


